Goncalves Joana, Chief Medical Officer at ORKA, has been a consistent seller of company stock over the past year, with Form 4 filings showing 37 total transactions, all in a single equity. The pattern is unambiguous: zero open-market purchases and roughly $3.03 million in total sales, with no acquisitions or awards recorded. The most recent activity, spanning February through July 2026, shows a steady cadence of sell transactions on or around the 15th of each month, typically executed in multiple tranches per filing date.
The selling is concentrated in ORKA shares, with individual transactions ranging from roughly $6,400 to $351,500. The largest single-day disposals occurred on July 15, 2026, when Joana sold shares worth approximately $604,000 across four separate transactions, and on June 15, 2026, with sales totaling about $550,600. Each monthly filing also includes a small "M" code transaction valued at $23,940, representing an option exercise—a mechanical event that typically precedes the sale of the underlying shares. The consistent pairing of option exercises with immediate sales suggests a routine liquidation strategy rather than a one-off decision.
Over the trailing five months tracked in the filings, Joana has executed 20 sell transactions with no corresponding buys, reinforcing a clear bearish bias toward ORKA. The dollar values have fluctuated month to month—from roughly $226,000 in February to over $600,000 in July—but the direction has never wavered. While the filings do not indicate whether these sales are part of a pre-arranged 10b5-1 plan, the regularity and volume of disposals signal that Joana has been steadily reducing her stake in the company throughout the period.
AI-assisted summary